IDXX IDEXX Laboratories: Earnings per share for the trailing year

Official company branding of IDEXX Corp (IDXX)

Risks of declining veterinary spending and competition are constraining the growth of IDEXX Laboratories, Inc. (IDXX). The 12-month annual growth in earnings per share on the GURU.Markets dynamic chart confirms investor confidence, where the current parameter equals 17.00. Stable revenue is secured by the clinics' reliance on consumables, while the expansion of the installed base of instruments effectively scales the business's margins.

IDXX idexx.com Earnings per share for the last twelve months (02/11/2024 - 11/18/2026)

Financial and market metric breakdowns for IDEXX Lab (IDXX)

- current quotes and average value forecast:
- company stock capitalization data:
Fundamental company valuation:IDXX, IDEXX
Product sample of IDEXX Laboratories

This indicator reflects the rate of change in net income per share over the last twelve months relative to the same period last year. By analyzing the annual growth rate of TTM net income per share, an investor assesses the efficiency of business scaling and the sustainability of margins. The metric is calculated as the percentage deviation of the current rolling EPS from the base value of one year ago. For IDEXX Laboratories, Inc. (IDXX), this growth confirms the monetization of technological superiority in veterinary diagnostics and high customer switching costs for alternative software.